The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis
Renal cell carcinoma (RCC) is characterized by a propensity for extension into the renal vein and inferior vena cava (IVC) and is associated with poor prognosis. BAP1 mutation, which occurs in about 15% of patients with clear cell RCC (ccRCC), also predicts poor prognosis. The aim of this study was to elucidate the association between BAP1 protein expression and clinicopathological outcomes in patients with nonmetastatic ccRCC with an IVC tumor thrombus (IVCTT).
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Suguru Oka, Naoko Inoshita, Yuji Miura, Ryosuke Oki, Yu Miyama, Shoichi Nagamoto, Kohei Ogawa, Kazushige Sakaguchi, Chihiro Kondoh, Kazuhiro Kurosawa, Shinji Urakami, Toshimi Takano, Toshikazu Okaneya Tags: Original article Source Type: research
More News: Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Study | Thrombosis | Urology & Nephrology